Lower-middle income (World Bank) vs Papua New Guinea: Previously treated cases tested for RR-/MDR-TB
Lower-middle income (World Bank)
85.0%
in 2024
Papua New Guinea
100.0%
in 2024
Lower-middle income (World Bank) rank
4th
Papua New Guinea rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Lower-middle income (World Bank)
- Papua New Guinea
How they compare
Papua New Guinea currently reports 100.0% against 85.0% in Lower-middle income (World Bank), a difference of 15.0%.
That makes Papua New Guinea's figure about 1.2 times Lower-middle income (World Bank)'s.
The two have swapped places 2 times across 5 shared years of data; in 2015 it was Papua New Guinea ahead.
Lower-middle income (World Bank) ranks 4th and Papua New Guinea ranks 1st of 11 groups.
Across the 2 decades both report, Lower-middle income (World Bank) averaged higher in 1 and Papua New Guinea in 1.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 67.0% | 43.3% | 23.7% | Lower-middle income (World Bank) |
| 2020s | 85.5% | 100.0% | 14.5% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Lower-middle income (World Bank) or Papua New Guinea?
- Papua New Guinea, at 100.0% against 85.0% in Lower-middle income (World Bank) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Lower-middle income (World Bank) and Papua New Guinea?
- 15.0%, with Papua New Guinea ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Papua New Guinea?
- 5 years are reported by both, from 2015 to 2024.
- How do Lower-middle income (World Bank) and Papua New Guinea rank globally for previously treated cases tested for rr-/mdr-tb?
- Lower-middle income (World Bank) ranks 4th and Papua New Guinea ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.